Readily Awarded Grant from Bio-X Accelerate Program
Readily Diagnostics has been awarded a grant from the Bio-X Accelerate Program to advance the development of its next-generation rapid diagnostic tests for respiratory diseases.
Bio-X Accelerate is a Swedish life science accelerator programme focused on supporting projects that create measurable impact in healthcare, industry and society. Selection is competitive and based on the project's potential to address well-defined clinical needs.
The grant will enable Readily to accelerate both development and market introduction of its diagnostic technology — bringing rapid, instrument-free infectious disease testing closer to clinical use.
"We see this as confirmation that our diagnostic tests will have a significant impact in healthcare by providing faster and more accurate diagnoses, ultimately giving patients the right care faster," said Liza Löf, CEO of Readily Diagnostics.
The project is financed by the European Regional Development Fund (ERDF) through the Swedish Agency for Economic and Regional Growth via STUNS.